← Eichor
Study identifier: NCT06644807 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Phantom Limb Pain Suppression Using Neuromodulation Methods

Condition: Phantom Limb Pain  ·  Sponsor: Skolkovo Institute of Science and Technology

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study assesses the effectiveness of neuromodulation in alleviating pain through the stimulation of peripheral nerves. The research involves implanting electrodes for test stimulation of peripheral nerves (PNS - Peripheral Nerve Stimulation), spinal cord (SCS - Spinal Cord Stimulation), dorsal root ganglia (DRGS - Dorsal Root Ganglion Stimulation), and motor cortex (MCS - Motor Cortex Stimulation). The study aims to explore the use of neuromodulation for pain relief in patients experiencing pain due to upper or lower limb amputation.

This description comes directly from the study's public registry record.

Talk to the study team

Yury Matveenko  ·  +79163843070  ·  medtream@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of RussiaMoscow, Moscow, RussiaRecruiting
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of RussiaMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06644807